The global next-generation sequencing market size was estimated at USD 9.56 billion in 2024 and is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. This growth is driven by the increasing demand for advanced genomic research, rising applications of next-generation sequencing (NGS) in clinical diagnostics, and ongoing technological advancements in sequencing platforms.
This product will be delivered within 2 business days.
Global Next-Generation Sequencing Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, the analyst has segmented the next-generation sequencing market based on technology, product, workflow, end-use, and region.Technology Outlook (Revenue, USD Million, 2021-2033)
- WGS
- Whole Exome Sequencing
- Targeted Sequencing & Resequencing
- Others
Product Outlook (Revenue, USD Million, 2021-2033)
- Platform
- Consumables
Application Outlook (Revenue, USD Million, 2021-2033)
- Oncology
- Clinical Investigation
- Reproductive Health
- HLA Typing/Immune System Monitoring
- Metagenomics, Epidemiology & Drug Development
- Agrigenomics & Forensics
- Consumer Genomics
Workflow Outlook (Revenue, USD Million, 2021-2033)
- Pre-Sequencing
- Sequencing
End Use Outlook (Revenue, USD Million, 2021-2033)
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Other Users
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Why You Should Buy This Report
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
Report Deliverables
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Technology Segment
1.1.2. Product Segment
1.1.3. Workflow Segment
1.1.4. Application Segment
1.1.5. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
1.1.1. Technology Segment
1.1.2. Product Segment
1.1.3. Workflow Segment
1.1.4. Application Segment
1.1.5. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Market Drivers Analysis
3.4.1.1. Decreasing costs for genetic sequencing
3.4.1.2. Development of companion diagnostics and personalized medicine
3.4.1.3. Rising clinical opportunity for NGS technology
3.4.1.4. Technological advancements in cloud computing
3.4.2. Market Restraint Analysis
3.4.2.1. Lack of computational efficiency for data management
3.4.2.2. Non-value-based NGS reimbursement policy and regulation status
3.4.2.3. Challenges associated with NGS implementation
3.5. Market Analysis Tools
3.5.1. SWOT Analysis; by Factor (Political & Legal, Economic and Technological)
3.5.2. Porter’s Five Forces Analysis
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Market Drivers Analysis
3.4.1.1. Decreasing costs for genetic sequencing
3.4.1.2. Development of companion diagnostics and personalized medicine
3.4.1.3. Rising clinical opportunity for NGS technology
3.4.1.4. Technological advancements in cloud computing
3.4.2. Market Restraint Analysis
3.4.2.1. Lack of computational efficiency for data management
3.4.2.2. Non-value-based NGS reimbursement policy and regulation status
3.4.2.3. Challenges associated with NGS implementation
3.5. Market Analysis Tools
3.5.1. SWOT Analysis; by Factor (Political & Legal, Economic and Technological)
3.5.2. Porter’s Five Forces Analysis
Chapter 4. Technology Business Analysis
4.1. Segment Dashboard
4.2. Next Generation Sequencing Data Analysis Market: Technology Movement Analysis
4.3. Targeted Sequencing & Resequencing
4.3.1. Targeted Sequencing & Resequencing Market Estimates and Forecast, 2021-2033 (USD Million)
4.3.2. DNA-Based Targeted Sequencing & Resequencing
4.3.2.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2021-2033 (USD Million)
4.3.3. RNA-Based Targeted Sequencing & Resequencing
4.3.3.1. RNA -based targeted sequencing & resequencing market estimates and forecast, 2021-2033 (USD Million)
4.4. Whole Genome Sequencing
4.4.1. Whole Genome Sequencing Market Estimates and Forecast, 2021-2033 (USD Million)
4.5. Whole Exome Sequencing
4.5.1. Whole Exome Sequencing Market Estimates and Forecast, 2021-2033 (USD Million)
4.2. Next Generation Sequencing Data Analysis Market: Technology Movement Analysis
4.3. Targeted Sequencing & Resequencing
4.3.1. Targeted Sequencing & Resequencing Market Estimates and Forecast, 2021-2033 (USD Million)
4.3.2. DNA-Based Targeted Sequencing & Resequencing
4.3.2.1. DNA-based targeted sequencing & resequencing market estimates and forecast, 2021-2033 (USD Million)
4.3.3. RNA-Based Targeted Sequencing & Resequencing
4.3.3.1. RNA -based targeted sequencing & resequencing market estimates and forecast, 2021-2033 (USD Million)
4.4. Whole Genome Sequencing
4.4.1. Whole Genome Sequencing Market Estimates and Forecast, 2021-2033 (USD Million)
4.5. Whole Exome Sequencing
4.5.1. Whole Exome Sequencing Market Estimates and Forecast, 2021-2033 (USD Million)
Chapter 5. Product Business Analysis
5.1. Segment Dashboard
5.2. Next Generation Sequencing Data Analysis Market: Product Movement Analysis
5.3. Platforms
5.3.1. Platforms Market Estimates and Forecast, 2021-2033 (USD Million)
5.3.2. Sequencing
5.3.2.1. Sequencing Platforms Market Estimates and Forecast, 2021-2033 (USD Million)
5.3.3. Data Analysis
5.3.3.1. Data Analysis Platforms Market Estimates and Forecast, 2021-2033 (USD Million)
5.4. Consumables
5.4.1. Consumables Market Estimates and Forecast, 2021-2033 (USD Million)
5.4.2. Sample Preparation
5.4.2.1. Sample Preparation Market Estimates and Forecast, 2021-2033 (USD Million)
5.4.3. Target Enrichment
5.4.3.1. Target Enrichment Market Estimates and Forecast, 2021-2033 (USD Million)
5.4.4. Others
5.4.4.1. Others Market Estimates and Forecast, 2021-2033 (USD Million)
5.2. Next Generation Sequencing Data Analysis Market: Product Movement Analysis
5.3. Platforms
5.3.1. Platforms Market Estimates and Forecast, 2021-2033 (USD Million)
5.3.2. Sequencing
5.3.2.1. Sequencing Platforms Market Estimates and Forecast, 2021-2033 (USD Million)
5.3.3. Data Analysis
5.3.3.1. Data Analysis Platforms Market Estimates and Forecast, 2021-2033 (USD Million)
5.4. Consumables
5.4.1. Consumables Market Estimates and Forecast, 2021-2033 (USD Million)
5.4.2. Sample Preparation
5.4.2.1. Sample Preparation Market Estimates and Forecast, 2021-2033 (USD Million)
5.4.3. Target Enrichment
5.4.3.1. Target Enrichment Market Estimates and Forecast, 2021-2033 (USD Million)
5.4.4. Others
5.4.4.1. Others Market Estimates and Forecast, 2021-2033 (USD Million)
Chapter 6. Application Business Analysis
6.1. Segment Dashboard
6.2. Next Generation Sequencing Data Analysis Market: Application Movement Analysis
6.3. Oncology
6.3.1. Oncology Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.2. Diagnostics & Screening
6.3.2.1. Diagnostics & Screening Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.2.2. Oncology screening
6.3.2.2.1. Oncology Screening Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.2.2.2. Sporadic Cancer Screening Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.2.2.3. Inherited Cancer Screening Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.2.3. Companion diagnostics
6.3.2.3.1. Companion Diagnostics Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.2.4. Other Diagnostics
6.3.2.4.1. Other Diagnostics Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.3. Research Studies
6.3.3.1. Research Studies Market Estimates and Forecast, 2021-2033 (USD Million)
6.4. Clinical Investigation
6.4.1. Clinical Investigation Market Estimates and Forecast, 2021-2033 (USD Million)
6.4.2. Infectious Diseases
6.4.2.1. Infectious Diseases Market Estimates and Forecast, 2021-2033 (USD Million)
6.4.3. Idiopathic Diseases
6.4.3.1. Idiopathic Diseases Market Estimates and Forecast, 2021-2033 (USD Million)
6.4.4. Inherited Diseases
6.4.4.1. Inherited Diseases Market Estimates and Forecast, 2021-2033 (USD Million)
6.4.5. Non-communicable/other Diseases
6.4.5.1. Reproductive Health Market Estimates and Forecast, 2021-2033 (USD Million)
6.5. Reproductive Health
6.5.1. Clinical Investigation Market Estimates and Forecast, 2021-2033 (USD Million)
6.5.2. NIPT
6.5.2.1. NIPT Market Estimates and Forecast, 2021-2033 (USD Million)
6.5.2.2. Aneuploidy
6.5.2.2.1. Aneuploidy Market Estimates and Forecast, 2021-2033 (USD Million)
6.5.2.3. Microdeletions
6.5.2.3.1. Microdeletions Market Estimates and Forecast, 2021-2033 (USD Million)
6.5.3. PGT
6.5.3.1. PGT Market Estimates and Forecast, 2021-2033 (USD Million)
6.5.4. Newborn Genetic Screening
6.5.4.1. Newborn Genetic Screening Market Estimates and Forecast, 2021-2033 (USD Million)
6.5.5. Single Gene Analysis Market
6.5.5.1. Single Gene Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
6.6. HLA Typing/Immune System Monitoring
6.6.1. HLA Typing/Immune System Monitoring Market Estimates and Forecast, 2021-2033 (USD Million)
6.7. Metagenomics, Epidemiology & Drug Development
6.7.1. Metagenomics, Epidemiology & Drug Development Market Estimates and Forecast, 2021-2033 (USD Million)
6.8. Agrigenomics & Forensics
6.8.1. Agrigenomics & Forensics Market Estimates and Forecast, 2021-2033 (USD Million)
6.9. Consumer Genomics
6.9.1. Consumer Genomics Market Estimates and Forecast, 2021-2033 (USD Million)
6.2. Next Generation Sequencing Data Analysis Market: Application Movement Analysis
6.3. Oncology
6.3.1. Oncology Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.2. Diagnostics & Screening
6.3.2.1. Diagnostics & Screening Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.2.2. Oncology screening
6.3.2.2.1. Oncology Screening Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.2.2.2. Sporadic Cancer Screening Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.2.2.3. Inherited Cancer Screening Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.2.3. Companion diagnostics
6.3.2.3.1. Companion Diagnostics Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.2.4. Other Diagnostics
6.3.2.4.1. Other Diagnostics Market Estimates and Forecast, 2021-2033 (USD Million)
6.3.3. Research Studies
6.3.3.1. Research Studies Market Estimates and Forecast, 2021-2033 (USD Million)
6.4. Clinical Investigation
6.4.1. Clinical Investigation Market Estimates and Forecast, 2021-2033 (USD Million)
6.4.2. Infectious Diseases
6.4.2.1. Infectious Diseases Market Estimates and Forecast, 2021-2033 (USD Million)
6.4.3. Idiopathic Diseases
6.4.3.1. Idiopathic Diseases Market Estimates and Forecast, 2021-2033 (USD Million)
6.4.4. Inherited Diseases
6.4.4.1. Inherited Diseases Market Estimates and Forecast, 2021-2033 (USD Million)
6.4.5. Non-communicable/other Diseases
6.4.5.1. Reproductive Health Market Estimates and Forecast, 2021-2033 (USD Million)
6.5. Reproductive Health
6.5.1. Clinical Investigation Market Estimates and Forecast, 2021-2033 (USD Million)
6.5.2. NIPT
6.5.2.1. NIPT Market Estimates and Forecast, 2021-2033 (USD Million)
6.5.2.2. Aneuploidy
6.5.2.2.1. Aneuploidy Market Estimates and Forecast, 2021-2033 (USD Million)
6.5.2.3. Microdeletions
6.5.2.3.1. Microdeletions Market Estimates and Forecast, 2021-2033 (USD Million)
6.5.3. PGT
6.5.3.1. PGT Market Estimates and Forecast, 2021-2033 (USD Million)
6.5.4. Newborn Genetic Screening
6.5.4.1. Newborn Genetic Screening Market Estimates and Forecast, 2021-2033 (USD Million)
6.5.5. Single Gene Analysis Market
6.5.5.1. Single Gene Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
6.6. HLA Typing/Immune System Monitoring
6.6.1. HLA Typing/Immune System Monitoring Market Estimates and Forecast, 2021-2033 (USD Million)
6.7. Metagenomics, Epidemiology & Drug Development
6.7.1. Metagenomics, Epidemiology & Drug Development Market Estimates and Forecast, 2021-2033 (USD Million)
6.8. Agrigenomics & Forensics
6.8.1. Agrigenomics & Forensics Market Estimates and Forecast, 2021-2033 (USD Million)
6.9. Consumer Genomics
6.9.1. Consumer Genomics Market Estimates and Forecast, 2021-2033 (USD Million)
Chapter 7. Workflow Business Analysis
7.1. Segment Dashboard
7.2. Next Generation Sequencing Data Analysis Market: Workflow Movement Analysis
7.3. Presequencing
7.3.1. Presequencing Market Estimates and Forecast, 2021-2033 (USD Million)
7.3.2. Nucleic Acid Extraction
7.3.2.1. Nucleic Acid Extraction Market Estimates and Forecast, 2021-2033 (USD Million)
7.3.3. Library Preparation
7.3.3.1. Library Preparation Market Estimates and Forecast, 2021-2033 (USD Million)
7.4. Sequencing
7.4.1. Sequencing Market Estimates and Forecast, 2021-2033 (USD Million)
7.5. Data Analysis
7.5.1. Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
7.5.2. Primary Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
7.5.2.1. Primary Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
7.5.3. Secondary Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
7.5.3.1. Secondary Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
7.5.4. Tertiary Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
7.5.4.1. Tertiary Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
7.2. Next Generation Sequencing Data Analysis Market: Workflow Movement Analysis
7.3. Presequencing
7.3.1. Presequencing Market Estimates and Forecast, 2021-2033 (USD Million)
7.3.2. Nucleic Acid Extraction
7.3.2.1. Nucleic Acid Extraction Market Estimates and Forecast, 2021-2033 (USD Million)
7.3.3. Library Preparation
7.3.3.1. Library Preparation Market Estimates and Forecast, 2021-2033 (USD Million)
7.4. Sequencing
7.4.1. Sequencing Market Estimates and Forecast, 2021-2033 (USD Million)
7.5. Data Analysis
7.5.1. Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
7.5.2. Primary Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
7.5.2.1. Primary Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
7.5.3. Secondary Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
7.5.3.1. Secondary Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
7.5.4. Tertiary Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
7.5.4.1. Tertiary Data Analysis Market Estimates and Forecast, 2021-2033 (USD Million)
Chapter 8. End Use Business Analysis
8.1. Segment Dashboard
8.2. Next Generation Sequencing Market: End - Use Movement Analysis
8.3. Academic Research
8.3.1. Academic Research Market Estimates and Forecast, 2021-2033 (USD Million)
8.4. Clinical Research
8.4.1. Clinical Research Market Estimates and Forecast, 2021-2033 (USD Million)
8.5. Hospitals & Clinics
8.5.1. Hospitals & Clinics Market Estimates and Forecast, 2021-2033 (USD Million)
8.6. Pharmaceutical & Biotech Entities
8.6.1. Pharmaceutical & Biotech Entities Market Estimates and Forecast, 2021-2033 (USD Million)
8.7. Other Users
8.7.1. Other Users Market Estimates and Forecast, 2021-2033 (USD Million)
8.2. Next Generation Sequencing Market: End - Use Movement Analysis
8.3. Academic Research
8.3.1. Academic Research Market Estimates and Forecast, 2021-2033 (USD Million)
8.4. Clinical Research
8.4.1. Clinical Research Market Estimates and Forecast, 2021-2033 (USD Million)
8.5. Hospitals & Clinics
8.5.1. Hospitals & Clinics Market Estimates and Forecast, 2021-2033 (USD Million)
8.6. Pharmaceutical & Biotech Entities
8.6.1. Pharmaceutical & Biotech Entities Market Estimates and Forecast, 2021-2033 (USD Million)
8.7. Other Users
8.7.1. Other Users Market Estimates and Forecast, 2021-2033 (USD Million)
Chapter 9. Regional Business Analysis
9.1. Next Generation Sequencing Market Share by Region, 2024 & 2033
9.2. North America
9.2.1. North America next generation sequencing market, 2021-2033 (USD Million)
9.2.2. U.S.
9.2.2.1. Key country dynamics
9.2.2.2. U.S. next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.2.3. Target disease prevalence
9.2.2.4. Competitive scenario
9.2.2.5. Regulatory framework
9.2.2.6. Reimbursement scenario
9.2.3. Canada
9.2.3.1. Key country dynamics
9.2.3.2. Canada next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.3.3. Target disease prevalence
9.2.3.4. Competitive scenario
9.2.3.5. Regulatory framework
9.2.3.6. Reimbursement scenario
9.2.4. Mexico
9.2.4.1. Key country dynamics
9.2.4.2. Mexico next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.4.3. Target disease prevalence
9.2.4.4. Competitive scenario
9.2.4.5. Regulatory framework
9.2.4.6. Reimbursement scenario
9.2.5. Europe
9.2.6. Europe Next Generation Sequencing market, 2021-2033 (USD Million)
9.2.7. Germany
9.2.7.1. Key country dynamics
9.2.7.2. Germany next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.7.3. Target disease prevalence
9.2.7.4. Competitive scenario
9.2.7.5. Regulatory framework
9.2.7.6. Reimbursement scenario
9.2.8. UK
9.2.8.1. Key country dynamics
9.2.8.2. UK next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.8.3. Target disease prevalence
9.2.8.4. Competitive scenario
9.2.8.5. Regulatory framework
9.2.8.6. Reimbursement scenario
9.2.9. France
9.2.9.1. Key country dynamics
9.2.9.2. France next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.9.3. Target disease prevalence
9.2.9.4. Competitive scenario
9.2.9.5. Regulatory framework
9.2.9.6. Reimbursement scenario
9.2.10. Italy
9.2.10.1. Key country dynamics
9.2.10.2. Italy next generation sequencing (NGS) market estimates and forecasts, 2021-2033 (USD Million)
9.2.10.3. Target disease prevalence
9.2.10.4. Competitive scenario
9.2.10.5. Regulatory framework
9.2.10.6. Reimbursement scenario
9.2.11. Spain
9.2.11.1. Key country dynamics
9.2.11.2. Spain next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.11.3. Target disease prevalence
9.2.11.4. Competitive scenario
9.2.11.5. Regulatory framework
9.2.11.6. Reimbursement scenario
9.2.12. Denmark
9.2.12.1. Key country dynamics
9.2.12.2. Denmark next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.12.3. Target disease prevalence
9.2.12.4. Competitive scenario
9.2.12.5. Regulatory framework
9.2.12.6. Reimbursement scenario
9.2.13. Sweden
9.2.13.1. Key country dynamics
9.2.13.2. Sweden next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.13.3. Target disease prevalence
9.2.13.4. Competitive scenario
9.2.13.5. Regulatory framework
9.2.13.6. Reimbursement scenario
9.2.14. Norway
9.2.14.1. Key country dynamics
9.2.14.2. Norway next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.14.3. Target disease prevalence
9.2.14.4. Competitive scenario
9.2.14.5. Regulatory framework
9.2.14.6. Reimbursement scenario
9.3. Asia Pacific
9.3.1. Asia Pacific next generation sequencing market, 2021-2033 (USD Million)
9.3.2. Japan
9.3.2.1. Key country dynamics
9.3.2.2. Japan next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.3.2.3. Target disease prevalence
9.3.2.4. Competitive scenario
9.3.2.5. Regulatory framework
9.3.2.6. Reimbursement scenario
9.3.3. China
9.3.3.1. Key country dynamics
9.3.3.2. China next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.3.3.3. Target disease prevalence
9.3.3.4. Competitive scenario
9.3.3.5. Regulatory framework
9.3.3.6. Reimbursement scenario
9.3.4. India
9.3.4.1. Key country dynamics
9.3.4.2. India next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.3.4.3. Target disease prevalence
9.3.4.4. Competitive scenario
9.3.4.5. Regulatory framework
9.3.4.6. Reimbursement scenario
9.3.5. South Korea
9.3.5.1. Key country dynamics
9.3.5.2. South Korea next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.3.5.3. Target disease prevalence
9.3.5.4. Competitive scenario
9.3.5.5. Regulatory framework
9.3.5.6. Reimbursement scenario
9.3.6. Australia
9.3.6.1. Key country dynamics
9.3.6.2. Australia next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.3.6.3. Target disease prevalence
9.3.6.4. Competitive scenario
9.3.6.5. Regulatory framework
9.3.6.6. Reimbursement scenario
9.3.7. Thailand
9.3.7.1. Key country dynamics
9.3.7.2. Thailand next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.3.7.3. Target disease prevalence
9.3.7.4. Competitive scenario
9.3.7.5. Regulatory framework
9.3.7.6. Reimbursement scenario
9.4. Latin America
9.4.1. Latin America next generation sequencing market, 2021-2033 (USD Million)
9.4.2. Brazil
9.4.2.1. Key country dynamics
9.4.2.2. Brazil next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.4.2.3. Target disease prevalence
9.4.2.4. Competitive scenario
9.4.2.5. Regulatory framework
9.4.2.6. Reimbursement scenario
9.4.3. Argentina
9.4.3.1. Key country dynamics
9.4.3.2. Argentina next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.4.3.3. Target disease prevalence
9.4.3.4. Competitive scenario
9.4.3.5. Regulatory framework
9.4.3.6. Reimbursement scenario
9.5. MEA
9.5.1. MEA next generation sequencing market, 2021-2033 (USD Million)
9.5.2. South Africa
9.5.2.1. Key country dynamics
9.5.2.2. South Africa next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.5.2.3. Target disease prevalence
9.5.2.4. Competitive scenario
9.5.2.5. Regulatory framework
9.5.2.6. Reimbursement scenario
9.5.3. Saudi Arabia
9.5.3.1. Key country dynamics
9.5.3.2. Saudi Arabia next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.5.3.3. Target disease prevalence
9.5.3.4. Competitive scenario
9.5.3.5. Regulatory framework
9.5.3.6. Reimbursement scenario
9.5.4. UAE
9.5.4.1. Key country dynamics
9.5.4.2. UAE next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.5.4.3. Target disease prevalence
9.5.4.4. Competitive scenario
9.5.4.5. Regulatory framework
9.5.4.6. Reimbursement scenario
9.5.5. Kuwait
9.5.5.1. Key country dynamics
9.5.5.2. Kuwait next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.5.5.3. Target disease prevalence
9.5.5.4. Competitive scenario
9.5.5.5. Regulatory framework
9.5.5.6. Reimbursement scenario
9.2. North America
9.2.1. North America next generation sequencing market, 2021-2033 (USD Million)
9.2.2. U.S.
9.2.2.1. Key country dynamics
9.2.2.2. U.S. next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.2.3. Target disease prevalence
9.2.2.4. Competitive scenario
9.2.2.5. Regulatory framework
9.2.2.6. Reimbursement scenario
9.2.3. Canada
9.2.3.1. Key country dynamics
9.2.3.2. Canada next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.3.3. Target disease prevalence
9.2.3.4. Competitive scenario
9.2.3.5. Regulatory framework
9.2.3.6. Reimbursement scenario
9.2.4. Mexico
9.2.4.1. Key country dynamics
9.2.4.2. Mexico next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.4.3. Target disease prevalence
9.2.4.4. Competitive scenario
9.2.4.5. Regulatory framework
9.2.4.6. Reimbursement scenario
9.2.5. Europe
9.2.6. Europe Next Generation Sequencing market, 2021-2033 (USD Million)
9.2.7. Germany
9.2.7.1. Key country dynamics
9.2.7.2. Germany next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.7.3. Target disease prevalence
9.2.7.4. Competitive scenario
9.2.7.5. Regulatory framework
9.2.7.6. Reimbursement scenario
9.2.8. UK
9.2.8.1. Key country dynamics
9.2.8.2. UK next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.8.3. Target disease prevalence
9.2.8.4. Competitive scenario
9.2.8.5. Regulatory framework
9.2.8.6. Reimbursement scenario
9.2.9. France
9.2.9.1. Key country dynamics
9.2.9.2. France next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.9.3. Target disease prevalence
9.2.9.4. Competitive scenario
9.2.9.5. Regulatory framework
9.2.9.6. Reimbursement scenario
9.2.10. Italy
9.2.10.1. Key country dynamics
9.2.10.2. Italy next generation sequencing (NGS) market estimates and forecasts, 2021-2033 (USD Million)
9.2.10.3. Target disease prevalence
9.2.10.4. Competitive scenario
9.2.10.5. Regulatory framework
9.2.10.6. Reimbursement scenario
9.2.11. Spain
9.2.11.1. Key country dynamics
9.2.11.2. Spain next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.11.3. Target disease prevalence
9.2.11.4. Competitive scenario
9.2.11.5. Regulatory framework
9.2.11.6. Reimbursement scenario
9.2.12. Denmark
9.2.12.1. Key country dynamics
9.2.12.2. Denmark next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.12.3. Target disease prevalence
9.2.12.4. Competitive scenario
9.2.12.5. Regulatory framework
9.2.12.6. Reimbursement scenario
9.2.13. Sweden
9.2.13.1. Key country dynamics
9.2.13.2. Sweden next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.13.3. Target disease prevalence
9.2.13.4. Competitive scenario
9.2.13.5. Regulatory framework
9.2.13.6. Reimbursement scenario
9.2.14. Norway
9.2.14.1. Key country dynamics
9.2.14.2. Norway next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.2.14.3. Target disease prevalence
9.2.14.4. Competitive scenario
9.2.14.5. Regulatory framework
9.2.14.6. Reimbursement scenario
9.3. Asia Pacific
9.3.1. Asia Pacific next generation sequencing market, 2021-2033 (USD Million)
9.3.2. Japan
9.3.2.1. Key country dynamics
9.3.2.2. Japan next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.3.2.3. Target disease prevalence
9.3.2.4. Competitive scenario
9.3.2.5. Regulatory framework
9.3.2.6. Reimbursement scenario
9.3.3. China
9.3.3.1. Key country dynamics
9.3.3.2. China next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.3.3.3. Target disease prevalence
9.3.3.4. Competitive scenario
9.3.3.5. Regulatory framework
9.3.3.6. Reimbursement scenario
9.3.4. India
9.3.4.1. Key country dynamics
9.3.4.2. India next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.3.4.3. Target disease prevalence
9.3.4.4. Competitive scenario
9.3.4.5. Regulatory framework
9.3.4.6. Reimbursement scenario
9.3.5. South Korea
9.3.5.1. Key country dynamics
9.3.5.2. South Korea next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.3.5.3. Target disease prevalence
9.3.5.4. Competitive scenario
9.3.5.5. Regulatory framework
9.3.5.6. Reimbursement scenario
9.3.6. Australia
9.3.6.1. Key country dynamics
9.3.6.2. Australia next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.3.6.3. Target disease prevalence
9.3.6.4. Competitive scenario
9.3.6.5. Regulatory framework
9.3.6.6. Reimbursement scenario
9.3.7. Thailand
9.3.7.1. Key country dynamics
9.3.7.2. Thailand next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.3.7.3. Target disease prevalence
9.3.7.4. Competitive scenario
9.3.7.5. Regulatory framework
9.3.7.6. Reimbursement scenario
9.4. Latin America
9.4.1. Latin America next generation sequencing market, 2021-2033 (USD Million)
9.4.2. Brazil
9.4.2.1. Key country dynamics
9.4.2.2. Brazil next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.4.2.3. Target disease prevalence
9.4.2.4. Competitive scenario
9.4.2.5. Regulatory framework
9.4.2.6. Reimbursement scenario
9.4.3. Argentina
9.4.3.1. Key country dynamics
9.4.3.2. Argentina next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.4.3.3. Target disease prevalence
9.4.3.4. Competitive scenario
9.4.3.5. Regulatory framework
9.4.3.6. Reimbursement scenario
9.5. MEA
9.5.1. MEA next generation sequencing market, 2021-2033 (USD Million)
9.5.2. South Africa
9.5.2.1. Key country dynamics
9.5.2.2. South Africa next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.5.2.3. Target disease prevalence
9.5.2.4. Competitive scenario
9.5.2.5. Regulatory framework
9.5.2.6. Reimbursement scenario
9.5.3. Saudi Arabia
9.5.3.1. Key country dynamics
9.5.3.2. Saudi Arabia next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.5.3.3. Target disease prevalence
9.5.3.4. Competitive scenario
9.5.3.5. Regulatory framework
9.5.3.6. Reimbursement scenario
9.5.4. UAE
9.5.4.1. Key country dynamics
9.5.4.2. UAE next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.5.4.3. Target disease prevalence
9.5.4.4. Competitive scenario
9.5.4.5. Regulatory framework
9.5.4.6. Reimbursement scenario
9.5.5. Kuwait
9.5.5.1. Key country dynamics
9.5.5.2. Kuwait next generation sequencing market estimates and forecasts, 2021-2033 (USD Million)
9.5.5.3. Target disease prevalence
9.5.5.4. Competitive scenario
9.5.5.5. Regulatory framework
9.5.5.6. Reimbursement scenario
Chapter 10. Competitive Landscape
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2024
10.4. Company Profiles/Listing
10.4.1. Illumina
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. F. Hoffman-La Roche Ltd.
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. QIAGEN
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Thermo Fisher Scientific, Inc.
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Bio-Rad Laboratories, Inc.
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Oxford Nanopore Technologies
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Revvity, Inc.
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. PacBio
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Merk KGaA
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. BGI
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2024
10.4. Company Profiles/Listing
10.4.1. Illumina
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. F. Hoffman-La Roche Ltd.
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. QIAGEN
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Thermo Fisher Scientific, Inc.
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Bio-Rad Laboratories, Inc.
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Oxford Nanopore Technologies
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Revvity, Inc.
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. PacBio
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Merk KGaA
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. BGI
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 North America next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 4 North America next generation sequencing market, by product, 2021-2033 (USD Million)
Table 5 North America next generation sequencing market, by application, 2021-2033 (USD Million)
Table 6 North America next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 7 North America next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 8 US next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 9 US next generation sequencing market, by product, 2021-2033 (USD Million)
Table 10 US next generation sequencing market, by application, 2021-2033 (USD Million)
Table 11 US next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 12 US next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 13 Canada next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 14 Canada next generation sequencing market, by product, 2021-2033 (USD Million)
Table 15 Canada next generation sequencing market, by application, 2021-2033 (USD Million)
Table 16 Canada next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 17 Canada next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 18 Mexico next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 19 Mexico next generation sequencing market, by product, 2021-2033 (USD Million)
Table 20 Mexico next generation sequencing market, by application, 2021-2033 (USD Million)
Table 21 Mexico next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 22 Mexico next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 23 Europe next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 24 Europe next generation sequencing market, by product, 2021-2033 (USD Million)
Table 25 Europe next generation sequencing market, by application, 2021-2033 (USD Million)
Table 26 Europe next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 27 Europe next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 28 Germany next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 29 Germany next generation sequencing market, by product, 2021-2033 (USD Million)
Table 30 Germany next generation sequencing market, by application, 2021-2033 (USD Million)
Table 31 Germany next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 32 Germany next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 33 UK next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 34 UK next generation sequencing market, by product, 2021-2033 (USD Million)
Table 35 UK next generation sequencing market, by application, 2021-2033 (USD Million)
Table 36 UK next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 37 UK next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 38 France next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 39 France next generation sequencing market, by product, 2021-2033 (USD Million)
Table 40 France next generation sequencing market, by application, 2021-2033 (USD Million)
Table 41 France next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 42 France next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 43 Italy next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 44 Italy next generation sequencing market, by product, 2021-2033 (USD Million)
Table 45 Italy next generation sequencing market, by application, 2021-2033 (USD Million)
Table 46 Italy next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 47 Italy next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 48 Spain next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 49 Spain next generation sequencing market, by product, 2021-2033 (USD Million)
Table 50 Spain next generation sequencing market, by application, 2021-2033 (USD Million)
Table 51 Spain next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 52 Spain next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 53 Denmark next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 54 Denmark next generation sequencing market, by product, 2021-2033 (USD Million)
Table 55 Denmark next generation sequencing market, by application, 2021-2033 (USD Million)
Table 56 Denmark next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 57 Denmark next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 58 Sweden next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 59 Sweden next generation sequencing market, by product, 2021-2033 (USD Million)
Table 60 Sweden next generation sequencing market, by application, 2021-2033 (USD Million)
Table 61 Sweden next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 62 Sweden next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 63 Norway next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 64 Norway next generation sequencing market, by product, 2021-2033 (USD Million)
Table 65 Norway next generation sequencing market, by application, 2021-2033 (USD Million)
Table 66 Norway next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 67 Norway next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 68 Asia-Pacific next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 69 Asia-Pacific next generation sequencing market, by product, 2021-2033 (USD Million)
Table 70 Asia-Pacific next generation sequencing market, by application, 2021-2033 (USD Million)
Table 71 Asia-Pacific next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 72 Asia-Pacific next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 73 Japan next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 74 Japan next generation sequencing market, by product, 2021-2033 (USD Million)
Table 75 Japan next generation sequencing market, by application, 2021-2033 (USD Million)
Table 76 Japan next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 77 Japan next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 78 China next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 79 China next generation sequencing market, by product, 2021-2033 (USD Million)
Table 80 China next generation sequencing market, by application, 2021-2033 (USD Million)
Table 81 China next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 82 China next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 83 India next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 84 India next generation sequencing market, by product, 2021-2033 (USD Million)
Table 85 India next generation sequencing market, by application, 2021-2033 (USD Million)
Table 86 India next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 87 India next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 88 South Korea next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 89 South Korea next generation sequencing market, by product, 2021-2033 (USD Million)
Table 90 South Korea next generation sequencing market, by application, 2021-2033 (USD Million)
Table 91 South Korea next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 92 South Korea next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 93 Australia next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 94 Australia next generation sequencing market, by product, 2021-2033 (USD Million)
Table 95 Australia next generation sequencing market, by application, 2021-2033 (USD Million)
Table 96 Australia next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 97 Australia next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 98 Thailand next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 99 Thailand next generation sequencing market, by product, 2021-2033 (USD Million)
Table 100 Thailand next generation sequencing market, by application, 2021-2033 (USD Million)
Table 101 Thailand next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 102 Thailand next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 103 Latin America next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 104 Latin America next generation sequencing market, by product, 2021-2033 (USD Million)
Table 105 Latin America next generation sequencing market, by application, 2021-2033 (USD Million)
Table 106 Latin America next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 107 Latin America next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 108 Brazil next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 109 Brazil next generation sequencing market, by product, 2021-2033 (USD Million)
Table 110 Brazil next generation sequencing market, by application, 2021-2033 (USD Million)
Table 111 Brazil next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 112 Brazil next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 113 Argentina next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 114 Argentina next generation sequencing market, by product, 2021-2033 (USD Million)
Table 115 Argentina next generation sequencing market, by application, 2021-2033 (USD Million)
Table 116 Argentina next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 117 Argentina next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 118 Middle East & Africa next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 119 Middle East & Africa next generation sequencing market, by product, 2021-2033 (USD Million)
Table 120 Middle East & Africa next generation sequencing market, by application, 2021-2033 (USD Million)
Table 121 Middle East & Africa next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 122 Middle East & Africa next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 123 South Africa next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 124 South Africa next generation sequencing market, by product, 2021-2033 (USD Million)
Table 125 South Africa next generation sequencing market, by application, 2021-2033 (USD Million)
Table 126 South Africa next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 127 South Africa next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 128 Saudi Arabia next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 129 Saudi Arabia next generation sequencing market, by product, 2021-2033 (USD Million)
Table 130 Saudi Arabia next generation sequencing market, by application, 2021-2033 (USD Million)
Table 131 Saudi Arabia next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 132 Saudi Arabia next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 133 UAE next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 134 UAE next generation sequencing market, by product, 2021-2033 (USD Million)
Table 135 UAE next generation sequencing market, by application, 2021-2033 (USD Million)
Table 136 UAE next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 137 UAE next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 138 Kuwait next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 139 Kuwait next generation sequencing market, by product, 2021-2033 (USD Million)
Table 140 Kuwait next generation sequencing market, by application, 2021-2033 (USD Million)
Table 141 Kuwait next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 142 Kuwait next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 2 List of Abbreviations
Table 3 North America next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 4 North America next generation sequencing market, by product, 2021-2033 (USD Million)
Table 5 North America next generation sequencing market, by application, 2021-2033 (USD Million)
Table 6 North America next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 7 North America next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 8 US next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 9 US next generation sequencing market, by product, 2021-2033 (USD Million)
Table 10 US next generation sequencing market, by application, 2021-2033 (USD Million)
Table 11 US next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 12 US next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 13 Canada next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 14 Canada next generation sequencing market, by product, 2021-2033 (USD Million)
Table 15 Canada next generation sequencing market, by application, 2021-2033 (USD Million)
Table 16 Canada next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 17 Canada next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 18 Mexico next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 19 Mexico next generation sequencing market, by product, 2021-2033 (USD Million)
Table 20 Mexico next generation sequencing market, by application, 2021-2033 (USD Million)
Table 21 Mexico next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 22 Mexico next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 23 Europe next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 24 Europe next generation sequencing market, by product, 2021-2033 (USD Million)
Table 25 Europe next generation sequencing market, by application, 2021-2033 (USD Million)
Table 26 Europe next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 27 Europe next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 28 Germany next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 29 Germany next generation sequencing market, by product, 2021-2033 (USD Million)
Table 30 Germany next generation sequencing market, by application, 2021-2033 (USD Million)
Table 31 Germany next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 32 Germany next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 33 UK next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 34 UK next generation sequencing market, by product, 2021-2033 (USD Million)
Table 35 UK next generation sequencing market, by application, 2021-2033 (USD Million)
Table 36 UK next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 37 UK next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 38 France next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 39 France next generation sequencing market, by product, 2021-2033 (USD Million)
Table 40 France next generation sequencing market, by application, 2021-2033 (USD Million)
Table 41 France next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 42 France next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 43 Italy next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 44 Italy next generation sequencing market, by product, 2021-2033 (USD Million)
Table 45 Italy next generation sequencing market, by application, 2021-2033 (USD Million)
Table 46 Italy next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 47 Italy next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 48 Spain next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 49 Spain next generation sequencing market, by product, 2021-2033 (USD Million)
Table 50 Spain next generation sequencing market, by application, 2021-2033 (USD Million)
Table 51 Spain next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 52 Spain next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 53 Denmark next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 54 Denmark next generation sequencing market, by product, 2021-2033 (USD Million)
Table 55 Denmark next generation sequencing market, by application, 2021-2033 (USD Million)
Table 56 Denmark next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 57 Denmark next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 58 Sweden next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 59 Sweden next generation sequencing market, by product, 2021-2033 (USD Million)
Table 60 Sweden next generation sequencing market, by application, 2021-2033 (USD Million)
Table 61 Sweden next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 62 Sweden next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 63 Norway next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 64 Norway next generation sequencing market, by product, 2021-2033 (USD Million)
Table 65 Norway next generation sequencing market, by application, 2021-2033 (USD Million)
Table 66 Norway next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 67 Norway next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 68 Asia-Pacific next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 69 Asia-Pacific next generation sequencing market, by product, 2021-2033 (USD Million)
Table 70 Asia-Pacific next generation sequencing market, by application, 2021-2033 (USD Million)
Table 71 Asia-Pacific next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 72 Asia-Pacific next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 73 Japan next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 74 Japan next generation sequencing market, by product, 2021-2033 (USD Million)
Table 75 Japan next generation sequencing market, by application, 2021-2033 (USD Million)
Table 76 Japan next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 77 Japan next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 78 China next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 79 China next generation sequencing market, by product, 2021-2033 (USD Million)
Table 80 China next generation sequencing market, by application, 2021-2033 (USD Million)
Table 81 China next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 82 China next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 83 India next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 84 India next generation sequencing market, by product, 2021-2033 (USD Million)
Table 85 India next generation sequencing market, by application, 2021-2033 (USD Million)
Table 86 India next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 87 India next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 88 South Korea next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 89 South Korea next generation sequencing market, by product, 2021-2033 (USD Million)
Table 90 South Korea next generation sequencing market, by application, 2021-2033 (USD Million)
Table 91 South Korea next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 92 South Korea next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 93 Australia next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 94 Australia next generation sequencing market, by product, 2021-2033 (USD Million)
Table 95 Australia next generation sequencing market, by application, 2021-2033 (USD Million)
Table 96 Australia next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 97 Australia next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 98 Thailand next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 99 Thailand next generation sequencing market, by product, 2021-2033 (USD Million)
Table 100 Thailand next generation sequencing market, by application, 2021-2033 (USD Million)
Table 101 Thailand next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 102 Thailand next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 103 Latin America next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 104 Latin America next generation sequencing market, by product, 2021-2033 (USD Million)
Table 105 Latin America next generation sequencing market, by application, 2021-2033 (USD Million)
Table 106 Latin America next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 107 Latin America next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 108 Brazil next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 109 Brazil next generation sequencing market, by product, 2021-2033 (USD Million)
Table 110 Brazil next generation sequencing market, by application, 2021-2033 (USD Million)
Table 111 Brazil next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 112 Brazil next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 113 Argentina next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 114 Argentina next generation sequencing market, by product, 2021-2033 (USD Million)
Table 115 Argentina next generation sequencing market, by application, 2021-2033 (USD Million)
Table 116 Argentina next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 117 Argentina next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 118 Middle East & Africa next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 119 Middle East & Africa next generation sequencing market, by product, 2021-2033 (USD Million)
Table 120 Middle East & Africa next generation sequencing market, by application, 2021-2033 (USD Million)
Table 121 Middle East & Africa next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 122 Middle East & Africa next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 123 South Africa next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 124 South Africa next generation sequencing market, by product, 2021-2033 (USD Million)
Table 125 South Africa next generation sequencing market, by application, 2021-2033 (USD Million)
Table 126 South Africa next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 127 South Africa next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 128 Saudi Arabia next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 129 Saudi Arabia next generation sequencing market, by product, 2021-2033 (USD Million)
Table 130 Saudi Arabia next generation sequencing market, by application, 2021-2033 (USD Million)
Table 131 Saudi Arabia next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 132 Saudi Arabia next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 133 UAE next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 134 UAE next generation sequencing market, by product, 2021-2033 (USD Million)
Table 135 UAE next generation sequencing market, by application, 2021-2033 (USD Million)
Table 136 UAE next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 137 UAE next generation sequencing market, by end-use, 2021-2033 (USD Million)
Table 138 Kuwait next generation sequencing market, by technology, 2021-2033 (USD Million)
Table 139 Kuwait next generation sequencing market, by product, 2021-2033 (USD Million)
Table 140 Kuwait next generation sequencing market, by application, 2021-2033 (USD Million)
Table 141 Kuwait next generation sequencing market, by workflow, 2021-2033 (USD Million)
Table 142 Kuwait next generation sequencing market, by end-use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Next Generation Sequencing, Market Segmentation
Figure 8 Market Snapshot, 2024
Figure 9 Market Trends & Outlook
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
Figure 13 Porter’s Five Forces Analysis
Figure 14 Market Penetration Vs Growth Prospect Mapping, 2024
Figure 15 Global Next Generation Sequencing Market: Product Movement Analysis
Figure 16 Global Next Generation Sequencing Market, for Platforms, 2021-2033 (USD Million)
Figure 17 Global Next Generation Sequencing Market, for Sequencing, 2021-2033 (USD Million)
Figure 18 Global Next Generation Sequencing Market, for Data Analysis, 2021-2033 (USD Million)
Figure 19 Global Next Generation Sequencing Market, for Consumables, 2021-2033 (USD Million)
Figure 20 Global Next Generation Sequencing Market, for Sample Preparation, 2021-2033 (USD Million)
Figure 21 Global Next Generation Sequencing Market, for Target Enrichment, 2021-2033 (USD Million)
Figure 22 Global Next Generation Sequencing Market: Application, Movement Analysis
Figure 23 Global Next Generation Sequencing Market, for Oncology, 2021-2033 (USD Million)
Figure 24 Global Next Generation Sequencing Market, for Diagnostics & Screening, 2021-2033 (USD Million)
Figure 25 Global Next Generation Sequencing Market, for Screening, 2021-2033 (USD Million)
Figure 26 Global Next Generation Sequencing Market, for Sporadic Cancer, 2021-2033 (USD Million)
Figure 27 Global Next Generation Sequencing Market, for Inherited Cancer, 2021-2033 (USD Million)
Figure 28 Global Next Generation Sequencing Market, for Companion Diagnostics, 2021-2033 (USD Million)
Figure 29 Global Next Generation Sequencing Market, for Other Diagnostics, 2021-2033 (USD Million)
Figure 30 Global Next Generation Sequencing Market, for Research Studies, 2021-2033 (USD Million)
Figure 31 Global Next Generation Sequencing Market, for Clinical Investigation, 2021-2033 (USD Million)
Figure 32 Global Next Generation Sequencing Market for Infectious Diseases 2021-2033 (USD Million)
Figure 33 Global Next Generation Sequencing Market, for Idiopathic Diseases, 2021-2033 (USD Million)
Figure 34 Global Next Generation Sequencing Market, for Inherited Diseases, 2021-2033 (USD Million)
Figure 35 Global Next Generation Sequencing Market, for Non-Communicable/Other Diseases, 2021-2033 (USD Million)
Figure 36 Global Next Generation Sequencing Market, for Reproductive Health, 2021-2033 (USD Million)
Figure 37 Global Next Generation Sequencing Market, for NIPT, 2021-2033 (USD Million)
Figure 38 Global Next Generation Sequencing Market for Aneuploidy, 2021-2033 (USD Million)
Figure 39 Global Next Generation Sequencing Market, for Microdeletions, 2021-2033 (USD Million)
Figure 40 Global Next Generation Sequencing Market, for PGT, 2021-2033 (USD Million)
Figure 41 Global Next Generation Sequencing Market for Newborn Genetic Screening, 2021-2033 (USD Million)
Figure 42 Global Next Generation Sequencing Market, for Single Gene Analysis, 2021-2033 (USD Million)
Figure 43 Global Next Generation Sequencing Market, for HLA Typing/Immune System Monitoring, 2021-2033 (USD Million)
Figure 44 Global Next Generation Sequencing Market, for Metagenomics, Epidemiology & Drug Development, 2021-2033 (USD Million)
Figure 45 Global Next Generation Sequencing Market for Agrigenomics & Forensics, 2021-2033 (USD Million)
Figure 46 Global Next Generation Sequencing Market, for Consumer Genomics, 2021-2033 (USD Million)
Figure 47 Global Next Generation Sequencing Market: Technology Movement Analysis
Figure 48 Global Next Generation Sequencing Market for Whole Genome Sequencing, 2021-2033 (USD Million)
Figure 49 Global Next Generation Sequencing Market, for Whole Exome Sequencing, 2021-2033 (USD Million)
Figure 50 Global Next Generation Sequencing Market, for Targeted Sequencing & Resequencing, 2021-2033 (USD Million)
Figure 51 Global Next Generation Sequencing Market, for DNA-based, 2021-2033 (USD Million)
Figure 52 Global Next Generation Sequencing Market for RNA-based, 2021-2033 (USD Million)
Figure 53 Global Next Generation Sequencing Market: Workflow Movement Analysis
Figure 54 Global Next Generation Sequencing Market, for Pre-Sequencing, 2021-2033 (USD Million)
Figure 55 Global Next Generation Sequencing Market, for Nucleic Acid Extraction, 2021-2033 (USD Million)
Figure 56 Global Next Generation Sequencing Market for Library Prepartion, 2021-2033 (USD Million)
Figure 57 Global Next Generation Sequencing Market for Sequencing, 2021-2033 (USD Million)
Figure 58 Global Next Generation Sequencing Market for NGS Data Analysis, 2021-2033 (USD Million)
Figure 59 Global Next Generation Sequencing Market for NGS Primary Data Analysis, 2021-2033 (USD Million)
Figure 60 Global Next Generation Sequencing Market for NGS Secondary Data Analysis, 2021-2033 (USD Million)
Figure 61 Global Next Generation Sequencing Market for NGS Tertiary Data Analysis, 2021-2033 (USD Million)
Figure 62 Global Next Generation Sequencing Market: End-use Movement Analysis
Figure 63 Global Next Generation Sequencing Market for Academic Research, 2021-2033 (USD Million)
Figure 64 Global Next Generation Sequencing Market for Clinical Research, 2021-2033 (USD Million)
Figure 65 Global Next Generation Sequencing Market for Hospitals & Clinics, 2021-2033 (USD Million)
Figure 66 Global Next Generation Sequencing Market for Pharma & Biotech Entities, 2021-2033 (USD Million)
Figure 67 Global Next Generation Sequencing Market for Other users, 2021-2033 (USD Million)
Figure 68 Regional Marketplace: Key Takeaways Other users
Figure 69 Regional Outlook, 2022 & 2033
Figure 70 Global Next Generation Sequencing Market: Region Movement Analysis
Figure 71 North America Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 72 U.S. Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 73 Canada Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 74 Mexico Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 75 Europe Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 76 Germany Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 77 UK Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 78 France Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 79 Italy Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 80 Spain Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 81 Denmark Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 82 Sweden Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 83 Norway Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 84 Asia-Pacific Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 85 Japan Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 86 China Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 87 India Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 88 South Korea Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 89 Australia Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 90 Thailand Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 91 Latin America Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 92 Brazil Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 93 Argentina Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 94 Middle East and Africa Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 95 South Africa Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 96 Saudi Arabia Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 97 UAE Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 98 Kuwait Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 2 Information Procurement
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value Chain-Based Sizing & Forecasting
Figure 6 Market Formulation & Validation
Figure 7 Next Generation Sequencing, Market Segmentation
Figure 8 Market Snapshot, 2024
Figure 9 Market Trends & Outlook
Figure 10 Market Driver Relevance Analysis (Current & Future Impact)
Figure 11 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 12 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
Figure 13 Porter’s Five Forces Analysis
Figure 14 Market Penetration Vs Growth Prospect Mapping, 2024
Figure 15 Global Next Generation Sequencing Market: Product Movement Analysis
Figure 16 Global Next Generation Sequencing Market, for Platforms, 2021-2033 (USD Million)
Figure 17 Global Next Generation Sequencing Market, for Sequencing, 2021-2033 (USD Million)
Figure 18 Global Next Generation Sequencing Market, for Data Analysis, 2021-2033 (USD Million)
Figure 19 Global Next Generation Sequencing Market, for Consumables, 2021-2033 (USD Million)
Figure 20 Global Next Generation Sequencing Market, for Sample Preparation, 2021-2033 (USD Million)
Figure 21 Global Next Generation Sequencing Market, for Target Enrichment, 2021-2033 (USD Million)
Figure 22 Global Next Generation Sequencing Market: Application, Movement Analysis
Figure 23 Global Next Generation Sequencing Market, for Oncology, 2021-2033 (USD Million)
Figure 24 Global Next Generation Sequencing Market, for Diagnostics & Screening, 2021-2033 (USD Million)
Figure 25 Global Next Generation Sequencing Market, for Screening, 2021-2033 (USD Million)
Figure 26 Global Next Generation Sequencing Market, for Sporadic Cancer, 2021-2033 (USD Million)
Figure 27 Global Next Generation Sequencing Market, for Inherited Cancer, 2021-2033 (USD Million)
Figure 28 Global Next Generation Sequencing Market, for Companion Diagnostics, 2021-2033 (USD Million)
Figure 29 Global Next Generation Sequencing Market, for Other Diagnostics, 2021-2033 (USD Million)
Figure 30 Global Next Generation Sequencing Market, for Research Studies, 2021-2033 (USD Million)
Figure 31 Global Next Generation Sequencing Market, for Clinical Investigation, 2021-2033 (USD Million)
Figure 32 Global Next Generation Sequencing Market for Infectious Diseases 2021-2033 (USD Million)
Figure 33 Global Next Generation Sequencing Market, for Idiopathic Diseases, 2021-2033 (USD Million)
Figure 34 Global Next Generation Sequencing Market, for Inherited Diseases, 2021-2033 (USD Million)
Figure 35 Global Next Generation Sequencing Market, for Non-Communicable/Other Diseases, 2021-2033 (USD Million)
Figure 36 Global Next Generation Sequencing Market, for Reproductive Health, 2021-2033 (USD Million)
Figure 37 Global Next Generation Sequencing Market, for NIPT, 2021-2033 (USD Million)
Figure 38 Global Next Generation Sequencing Market for Aneuploidy, 2021-2033 (USD Million)
Figure 39 Global Next Generation Sequencing Market, for Microdeletions, 2021-2033 (USD Million)
Figure 40 Global Next Generation Sequencing Market, for PGT, 2021-2033 (USD Million)
Figure 41 Global Next Generation Sequencing Market for Newborn Genetic Screening, 2021-2033 (USD Million)
Figure 42 Global Next Generation Sequencing Market, for Single Gene Analysis, 2021-2033 (USD Million)
Figure 43 Global Next Generation Sequencing Market, for HLA Typing/Immune System Monitoring, 2021-2033 (USD Million)
Figure 44 Global Next Generation Sequencing Market, for Metagenomics, Epidemiology & Drug Development, 2021-2033 (USD Million)
Figure 45 Global Next Generation Sequencing Market for Agrigenomics & Forensics, 2021-2033 (USD Million)
Figure 46 Global Next Generation Sequencing Market, for Consumer Genomics, 2021-2033 (USD Million)
Figure 47 Global Next Generation Sequencing Market: Technology Movement Analysis
Figure 48 Global Next Generation Sequencing Market for Whole Genome Sequencing, 2021-2033 (USD Million)
Figure 49 Global Next Generation Sequencing Market, for Whole Exome Sequencing, 2021-2033 (USD Million)
Figure 50 Global Next Generation Sequencing Market, for Targeted Sequencing & Resequencing, 2021-2033 (USD Million)
Figure 51 Global Next Generation Sequencing Market, for DNA-based, 2021-2033 (USD Million)
Figure 52 Global Next Generation Sequencing Market for RNA-based, 2021-2033 (USD Million)
Figure 53 Global Next Generation Sequencing Market: Workflow Movement Analysis
Figure 54 Global Next Generation Sequencing Market, for Pre-Sequencing, 2021-2033 (USD Million)
Figure 55 Global Next Generation Sequencing Market, for Nucleic Acid Extraction, 2021-2033 (USD Million)
Figure 56 Global Next Generation Sequencing Market for Library Prepartion, 2021-2033 (USD Million)
Figure 57 Global Next Generation Sequencing Market for Sequencing, 2021-2033 (USD Million)
Figure 58 Global Next Generation Sequencing Market for NGS Data Analysis, 2021-2033 (USD Million)
Figure 59 Global Next Generation Sequencing Market for NGS Primary Data Analysis, 2021-2033 (USD Million)
Figure 60 Global Next Generation Sequencing Market for NGS Secondary Data Analysis, 2021-2033 (USD Million)
Figure 61 Global Next Generation Sequencing Market for NGS Tertiary Data Analysis, 2021-2033 (USD Million)
Figure 62 Global Next Generation Sequencing Market: End-use Movement Analysis
Figure 63 Global Next Generation Sequencing Market for Academic Research, 2021-2033 (USD Million)
Figure 64 Global Next Generation Sequencing Market for Clinical Research, 2021-2033 (USD Million)
Figure 65 Global Next Generation Sequencing Market for Hospitals & Clinics, 2021-2033 (USD Million)
Figure 66 Global Next Generation Sequencing Market for Pharma & Biotech Entities, 2021-2033 (USD Million)
Figure 67 Global Next Generation Sequencing Market for Other users, 2021-2033 (USD Million)
Figure 68 Regional Marketplace: Key Takeaways Other users
Figure 69 Regional Outlook, 2022 & 2033
Figure 70 Global Next Generation Sequencing Market: Region Movement Analysis
Figure 71 North America Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 72 U.S. Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 73 Canada Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 74 Mexico Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 75 Europe Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 76 Germany Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 77 UK Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 78 France Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 79 Italy Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 80 Spain Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 81 Denmark Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 82 Sweden Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 83 Norway Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 84 Asia-Pacific Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 85 Japan Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 86 China Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 87 India Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 88 South Korea Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 89 Australia Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 90 Thailand Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 91 Latin America Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 92 Brazil Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 93 Argentina Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 94 Middle East and Africa Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 95 South Africa Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 96 Saudi Arabia Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 97 UAE Next Generation Sequencing Market, 2021-2033 (USD Million)
Figure 98 Kuwait Next Generation Sequencing Market, 2021-2033 (USD Million)
Companies Mentioned
The companies profiled in this Next Generation Sequencing market report include:- Illumina
- F. Hoffman-La Roche Ltd.
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- PacBio
- Oxford Nanopore Technologies
- Revvity, Inc.
- Merck KGaA
- BGI
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | October 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 9.56 Billion |
| Forecasted Market Value ( USD | $ 42.25 Billion |
| Compound Annual Growth Rate | 18.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |


